Amain purpose of pharmacological research is to identify new drugs and
to determine their mechanism and site of action; such findings beside
s the therapeutical benefit will improve our knowledge of the physiopa
thology of the diseases. Usually, through the comparison in different
experimental models it is possible to determine the therapeutical and
collateral effects of a drug. Since there are a large number of experi
mental models it is not always convenient or efficient to search throu
gh all those models. Drug discrimination procedures (or more appropria
tely, stimulus control of drugs) may offer an efficient alternative to
establish the similarities and differences between drugs. The use of
these models has become extended, particularly within psychopharmacolo
gy, so it is convenient to understand the theoretical principles beyon
d the model to evaluate its deficiencies and worth. As to drug discrim
ination procedures, when comparing some drugs, one of them is establis
hed as discriminative stimulus; such drug, therefore, acquires the pro
perty of controlling behavior through the stimulus cue that it produce
s. Under the effect of this drug, the subject must learn to emit a par
ticular behavior which is correlated with a particular reinforce. On d
ifferent occasions, the same subject is trained to emit another respon
se correlated with some other reinforce. After performance criteria, t
he training drug is substituted on generalization tests with a novel o
r test drug to determine the similarity between them in a particular s
et of dimensions which were varied (effect of the drug, dose, mechanis
m of action, etc.). It is assumed that response selection will be a di
rect function of the similarity between the drugs. This particular mod
el is exemplified with serotonin partial agonists for the 5-HT1A recep
tor; this class of compounds were selected due to the great interest t
hese compounds have promoted after their possible application on depre
ssion, anxiety and food regulation, among other possible effects.